Labshake search
Citations for Tocris :
351 - 400 of 515 citations for 6 Chloro n propylpyridine 3 carboxamide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... Drug-evoked locomotor-like activities were induced by bath-applying 10 to 14 µM of N-methyl- D-aspartate (NMDA, Tocris) and serotonin (5-HT ...
-
bioRxiv - Neuroscience 2022Quote: ... females with regular estrous cycles underwent intrahippocampal injection of either KA (Tocris; 50 nl of 20 mM, n = 9 mice) or control sterile 0.9% saline (n = 6 mice ...
-
bioRxiv - Neuroscience 2020Quote: ... N-methyl D-aspartate (NMDA) receptors were blocked by the non-competitive NMDA receptor antagonist MK-801 (Tocris; 100 μM), co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... and (3-chloro-4-fluoro-N-[(4-([2-(phenylcarbonyl)hydrazino]carbonyl) phenyl)methyl]benzene-sulfonamide) (TCN-201) (Hansen et al., 2012)were obtained from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2019Quote: ... 15 min or 30 min in ACSF mixed with 6 μl of either quinpirole hydrochloride (Tocris; Cat# 1061 ...
-
bioRxiv - Neuroscience 2020Quote: ... JNJ16259685 and 2-Methyl-6-(phenylethynyl)pyridine (MPEP) hydrochloride were purchased from Tocris (Minneapolis MN, USA). (±)-Sulpiride was purchased from MilliporeSigma ...
-
bioRxiv - Bioengineering 2020Quote: Ectoderm differentiation was induced using Essential 6 (E6) medium supplemented with LDN-193189 (100 nM, Tocris) and A83-01 (2 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... Firing was recorded for 6 minutes before and after wash in of muscimol (50 μM, Tocris).
-
bioRxiv - Neuroscience 2023Quote: ... or 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX, 10 μM dissolved in H2O; Tocris Bioscience), or tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2023Quote: ... either alone or with 10 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, Tocris). Neurons were fixed with 4% PFA and 4% sucrose in PBS for 10 minutes at room temperature ...
-
bioRxiv - Cell Biology 2024Quote: ... Day 6: The medium was changed with the differentiation medium containing 0.25μM Sant-I (Tocris-#1974), 100ng/mL Noggin (Sino Biological-#10267) ...
-
bioRxiv - Neuroscience 2021Quote: ... In every animal a volume of 500nl of CNO (3 µM, Tocris) was infused at a rate of 0.5µl/min to target the PAG ...
-
bioRxiv - Genomics 2020Quote: ... ‘‘CBRa’’ medium consists of cSFDM base supplemented with 3 µM CHIR99021 (Tocris), 10 ng/mL recombinant human BMP4 (rhBMP4 ...
-
bioRxiv - Neuroscience 2021Quote: ... we added the CB1 receptor antagonist AM-251 (3 µM; Tocris, UK), or the NO synthase inhibitor L-NAME (200 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... and the glutamate receptor antagonist kynurenic acid (3 mM KynA, Tocris Bioscience) was included in the external solution to isolate GABA currents ...
-
bioRxiv - Neuroscience 2020Quote: ... the IS was supplemented with 3 mg/ml biocytin (Tocris, Bristol, UK) or 1.5 mg/ml neurobiotin (Vector Laboratories ...
-
bioRxiv - Genomics 2019Quote: ... and 12 uM of the GSK-3 inhibitor CHIR99021 trihydrochloride (Tocris, 4953). This medium was changed to base heart media 24 hours later (Day 1) ...
-
bioRxiv - Genomics 2021Quote: ... and 12uM of GSK-3 inhibitor CHIR99021 trihydrochloride (4953, Tocris, Bristol, UK). “Heart media” is composed of RPMI (15-040-CM ...
-
bioRxiv - Neuroscience 2022Quote: ... 3 dpf zebrafish were paralysed using α-bungarotoxin (1 mg/ml, Tocris) and embedded in 1.2% low melting point agarose ...
-
bioRxiv - Neuroscience 2022Quote: ... and 3-Deazaneplanocin A hydrochloride (DZN; 1 µg/dose in DMSO; Tocris). Tamoxifen (Sigma ...
-
bioRxiv - Neuroscience 2023Quote: ... Antagonists included the GABA-A blocker bicuculline methiodide (BCC, 3 μM, Tocris) by itself or ...
-
bioRxiv - Cell Biology 2023Quote: ... Media was then changed to cSFDM with 3 uM CHIR99021 (“C”; Tocris), recombinant human BMP4 (10 ng/ml ...
-
bioRxiv - Bioengineering 2023Quote: ... A83-01 (PeproTech, cat# 9094360 or Tocris, cat# 2939, 0.1-3 µM) and the impedance of monolayers was measured at 10 kHz at every 5 min for 48-96 h ...
-
bioRxiv - Cell Biology 2021Quote: ... 4 × 106 cells were seeded in a 21 cm2 dish and after 24 hours stimulated for ten minutes with 10 μM DAMGO ([D-Ala2, N-MePhe4, Gly-ol]-enkephalin, Tocris 1171) in DMEM medium (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2020Quote: ... The animals then rested for one to two weeks and were subsequently trained to discriminate the same odorant mixtures in sessions that took place 40 minutes after IP injection of 3mg/kg clozapine-N-oxide (CNO, Tocris, USA). 2 ...
-
bioRxiv - Cancer Biology 2019Quote: ... ADORA2b selective antagonist 4-(2,3,6,7-Tetrahydro-2, 6-dioxo-1-propyl-1H-purin-8-yl)-benzenesulfonic acid (PSB1115) (Tocris) (Lin et al. ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 μM of 2,3-dihydroxy 6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione (NBQX, 1044, Tocris Bioscience, UK), 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Neuroscience 2019Quote: ... Cells were split 12–30 h after transfection and plated on glass coverslips in the presence of 50 μM NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; Tocris Bioscience) to avoid AMPAR-mediated toxicity ...
-
bioRxiv - Neuroscience 2023Quote: ... in the presence of the mGluR5 antagonist 2-methyl-6 (phenylethynyl)-pyridine (MPEP, 25 μM; Tocris Bioscience) in ACSF at 31-33°C as previously (18) ...
-
bioRxiv - Neuroscience 2023Quote: ... to block Na channels or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM, Tocris, Minneapolis, USA) to block AMPA/kainate receptors were introduced to the standard ACSF.
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Neuroscience 2024Quote: ... All networks received a 20-min 50 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, in DMSO; Tocris, #0373) treatment on top of that ...
-
bioRxiv - Neuroscience 2024Quote: ... IPSCs were recorded in the presence of 10µM CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, Tocris 1045) and 50µM D-AP5 (D-2-amino-5-phosphonovalerate ...
-
bioRxiv - Pharmacology and Toxicology 2019Quote: ... The P2Y2R antagonist AR-C118925XX (5-[[5-(2,8-Dimethyl-5H-dibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furancarboxamide) was obtained from Tocris (Abingdon, UK). Subsequent dilutions of receptor ligand and other reagents were made in Krebs-Ringer Glucose phosphate buffer (KRG ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... as well as the P2Y2R antagonist AR-C118925XX (5-[[5-(2,8-Dimethyl-5H-dibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furancarboxamide) were obtained from Tocris (Abingdon, UK). Subsequent dilutions of receptor ligand and other reagents were made in Krebs-Ringer Glucose phosphate buffer (KRG ...
-
bioRxiv - Neuroscience 2023Quote: ... we recorded the firing properties of hM4Di-expressing neurons before and after applying 10 μM clozapine N-oxide (CNO, Tocris, Cat.#: 4936) (in ACSF).
-
bioRxiv - Neuroscience 2024Quote: ... rats were weighed and given an intraperitoneal injection of the DREADD agonist clozapine-N-oxide dihydrochloride (CNO, 2mg/kg, Bio-Techne Tocris, Minneapolis, MN) or vehicle saline (SAL) ...
-
bioRxiv - Developmental Biology 2021Quote: ... which consists of a N2B27 basal medium supplemented with 3 µM CHIR99021 (Tocris), 1µM PD0325901 (SelleckChem ...
-
bioRxiv - Cancer Biology 2020Quote: ... established tumorspheres were treated with either 0.5 µM or 3 µM CHIR99021 (Tocris) for 5 days ...
-
bioRxiv - Neuroscience 2021Quote: ... The craniotomy was then covered with 3% agar (MilliporeSigma) dissolved in aCSF (TOCRIS). The agar was prevented from drying out by covering it with silicone oil ...
-
bioRxiv - Neuroscience 2021Quote: ... hiPSCs were pretreated for 5 days with 3 μM SB431542 (Tocris, Bristol, UK), 3 μM dorsomorphin (Sigma Aldrich) ...
-
bioRxiv - Cancer Biology 2022Quote: ... 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was purchased from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2023Quote: ... The craniotomy was then covered with 3% agar (MilliporeSigma) dissolved in aCSF (TOCRIS). The agar was covered with silicone oil (60,000 centistokes ...
-
bioRxiv - Developmental Biology 2024Quote: ... This CBRa media consists of cSFDM containing 3 μm CHIR99021 (Tocris, No.4423), 10 ng/mL rhBMP4 (R&D ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with Y-27632 (Tocris, cat# 1254, 5 µM, 24 h, day –3). On days 0 and 1 ...
-
Dopamine depletion can be predicted by the aperiodic component of subthalamic local field potentialsbioRxiv - Neuroscience 2021Quote: ... 4 or 8 μl of 6-OHDA (5 μg in 1 μl saline containing 0.1% ascorbic acid; Tocris, Bristol ...
-
bioRxiv - Neuroscience 2019Quote: ... and NMDAR EPSCs were then isolated by addition of the AMPAR antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM; Tocris, Cat# 1044). NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM ...
-
bioRxiv - Immunology 2021Quote: ... cells were stimulated with HDM or the known AhR agonist FICZ (5,11-Dihydroindolo[3,2-b]carbazole-6-carboxaldehyde, Tocris Bioscience ...
-
bioRxiv - Molecular Biology 2021Quote: ... culture medium was replaced by E6 medium supplemented with 6 μM CHIR (Tocris, Bio-Techne, Abingdon, United Kingdom) to initiate differentiation (defined as day 0) ...
-
bioRxiv - Neuroscience 2020Quote: ... to allow outside-out patch recording and 30 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Cat#1044) was added to media post-transfection to avoid AMPAR-mediated toxicity.